These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2163012)

  • 41. Labeling of NMDA receptor channels by [3H]MK-801 in brain synaptic membranes treated with Triton X-100.
    Yoneda Y; Ogita K
    Brain Res; 1989 Oct; 499(2):305-14. PubMed ID: 2572302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex.
    Marvizón JC; Lewin AH; Skolnick P
    J Neurochem; 1989 Mar; 52(3):992-4. PubMed ID: 2465385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors.
    Martin DC; Plagenhoef M; Abraham J; Dennison RL; Aronstam RS
    Biochem Pharmacol; 1995 Mar; 49(6):809-17. PubMed ID: 7702639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abolition of the NMDA-mediated responses by a specific glycine antagonist, 6,7-dichloroquinoxaline-2,3-dione (DCQX).
    Yoneda Y; Ogita K
    Biochem Biophys Res Commun; 1989 Oct; 164(2):841-9. PubMed ID: 2554902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [3H]D-2-amino-5-phosphonopentanoate as a ligand for N-methyl-D-aspartate receptors in the mammalian central nervous system.
    Olverman HJ; Jones AW; Watkins JC
    Neuroscience; 1988 Jul; 26(1):1-15. PubMed ID: 2901689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo.
    Danysz W; Wroblewski JT; Brooker G; Costa E
    Brain Res; 1989 Feb; 479(2):270-6. PubMed ID: 2538209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solubilization of rat brain phencyclidine receptors in an active binding form that is sensitive to N-methyl-D-aspartate receptor ligands.
    Ambar I; Kloog Y; Sokolovsky M
    J Neurochem; 1988 Jul; 51(1):133-40. PubMed ID: 2898002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline.
    Willetts J; Balster RL
    J Pharmacol Exp Ther; 1989 Nov; 251(2):627-33. PubMed ID: 2553930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative.
    Singh L; Donald AE; Foster AC; Hutson PH; Iversen LL; Iversen SD; Kemp JA; Leeson PD; Marshall GR; Oles RJ
    Proc Natl Acad Sci U S A; 1990 Jan; 87(1):347-51. PubMed ID: 2153294
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of N-methyl-D-aspartate evoked sodium flux by MK-801.
    Ransom RW; Stec NL
    Brain Res; 1988 Mar; 444(1):25-32. PubMed ID: 3282615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca2+ fluxes and [3H]GABA release.
    Reynolds IJ; Harris KM; Miller RJ
    Eur J Pharmacol; 1989 Mar; 172(1):9-17. PubMed ID: 2541002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of 3-carboxy-5-phosphono-1,2,3,4-tetrahydroisoquinoline (SC-48981), a potent competitive N-methy-D-aspartate (NMDA) receptor antagonist, in vitro and in vivo.
    Vazquez ML; Garland DJ; Sun ET; Cler JA; Mick SJ; Hood WF; Monahan JB; Iyengar S; Rao TS
    Neurosci Lett; 1992 Feb; 135(2):149-52. PubMed ID: 1352628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective depression of the segmental polysynaptic reflex by phencyclidine and its analogs in the rat in vitro: interaction with N-methyl-D-aspartate receptors.
    Ohno Y; Warnick JE
    J Pharmacol Exp Ther; 1990 Jan; 252(1):246-52. PubMed ID: 1967645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exploration of phenyl-spaced 2-amino-(5-9)-phosphonoalkanoic acids as competitive N-methyl-D-aspartic acid antagonists.
    Bigge CF; Drummond JT; Johnson G; Malone T; Probert AW; Marcoux FW; Coughenour LL; Brahce LJ
    J Med Chem; 1989 Jul; 32(7):1580-90. PubMed ID: 2544728
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different modulation of the binding to two phencyclidine (PCP) receptor subtypes: effects of N-methyl-D-aspartate agonists and antagonists.
    Itzhak Y
    Neurosci Lett; 1989 Oct; 104(3):314-9. PubMed ID: 2573019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycine binding to rat cortex and spinal cord: binding characteristics and pharmacology reveal distinct populations of sites.
    White WF; Brown KL; Frank DM
    J Neurochem; 1989 Aug; 53(2):503-12. PubMed ID: 2545818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mode of binding of [3H]dibenzocycloalkenimine (MK-801) to the N-methyl-D-aspartate (NMDA) receptor and its therapeutic implication.
    Kloog Y; Nadler V; Sokolovsky M
    FEBS Lett; 1988 Mar; 230(1-2):167-70. PubMed ID: 2895019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The glycine site of the N-methyl-D-aspartate receptor channel: differences between the binding of HA-966 and of 7-chlorokynurenic acid.
    Kloog Y; Lamdani-Itkin H; Sokolovsky M
    J Neurochem; 1990 May; 54(5):1576-83. PubMed ID: 1691278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.